Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Keiji, Kita"'
Publikováno v:
Journal of Gastroenterology. 43:464-472
We carried out a multicenter study to evaluate the safety of recombinant human serum albumin (rHSA), developed using the methylotrophic yeast Pichia pastoris, during and after repeated administration in patients with liver cirrhosis.rHSA was administ
Autor:
Aiko Kawashima, Ikuyo Tsukamoto, Yasuko Murakami, Misako Okita, Takayo Kawakami, Keiji Kita, Tomoko Koyabu, Kouichi Takaguchi, Naoko Kakibuchi
Publikováno v:
Lipids. 43:325-333
Eicosapentaenoic acid (EPA) (1.8 g/day) was administered to 12 chronic hepatitis C patients receiving combination therapy of pegylated interferon (PEG-IFN) α-2b and ribavirin for 48 weeks (EPA group). Twelve patients were not administered EPA (contr
Autor:
Yasuhiro Miyake, Kohsaku Sakaguchi, Keiji Kita, Hiroshi Ikeda, Yasuyuki Araki, Haruhiko Kobashi, Yasushi Shiratori, Yasuhiro Makino, Yoshiaki Iwasaki, Masaharu Ando
Publikováno v:
Transplantation. 80:930-936
BACKGROUND Many patients with fulminant hepatic failure die before receiving liver transplantation because of the difficulty of pinpointing the suitable timing for liver transplantation. The revised King's College criteria are useful for patients wit
Autor:
Keiji Kita, Masaharu Ando, Shosaku Hayashi, Kouichi Takaguchi, Takao Tsuji, Osamu Kawamata, Takashi Nishihara, Hiromichi Ogawa, Atsuhiko Satou
Publikováno v:
Hepatology Research. 22:139-144
To elucidate the positive frequency of hepatitis B virus (HBV) DNA in patients with hepatitis B surface antigen (HBsAg) and antibody to hepatitis C virus (HCVAb) negative (NBNC) chronic liver disease, we detected serum HBV-DNA using the real-time det
Publikováno v:
Journal of the Japanese Society for Horticultural Science. 59:1-7
Tachibana (Citrus tachibana (Mak.) Tanaka) trees growing in the wild and cultivated in Japan were surveyed and analyzed for their isozyme genes. Many trees were observed in south-western areas from Izu Peninsula, Shizuoka Prefecture to Ishinami, Kush
Autor:
Yasuko Murakami, Naoko Kakibuchi, Tomoko Koyabu, Keiji Kita, Takayo Kawakami, Kouichi Takaguchi, Misako Okita, Aiko Kawashima
Publikováno v:
Journal of nutritional science and vitaminology. 53(3)
We investigated the effects of zinc supplementation on clinical observations in chronic hepatitis C patients receiving pegylated interferon (PEG-IFN) alpha-2b plus ribavirin combination therapy. Patients were randomly allocated to receive 150 mg pola
Autor:
Masaki, Wato, Tomoki, Inaba, Shigenao, Ishikawa, Kouichi, Takaguchi, Keiji, Kita, Kozo, Kawai
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 103(4)
A 48-year-old man was referred to our hospital because of anemia. Upper gastrointestinal endoscopy showed discolored depressive lesion like gastric cancer, 30mm in diameter, in the greater curvature of the upper gastric body. During the endoscopic ex
Autor:
Naoko Kakibuchi, Takayo Kawakami, Yasuko Murakami, Keiji Kita, Kouichi Takaguchi, Kayoko Tomioka, Misako Okita
Publikováno v:
Journal of nutritional science and vitaminology. 51(6)
Eicosapentaenoic acid (EPA) has been shown to exert anti-inflammatory actions. To evaluate the effects of EPA on chronic hepatitis C, we administered EPA ethyl ester capsules to patients receiving the combination therapy of interferon alpha-2b and ri
Autor:
Yasuyuki Araki, Toshiya Osawa, Hiroshi Ikeda, Toshinari Shimoe, Yoshiaki Iwasaki, Noriaki Hashimoto, Kouichi Takaguchi, Toshitsugu Kobatake, Masaharu Ando, Yasushi Shiratori, Minoru Tomita, Mitsuhiko Kawaguchi, Haruhiko Kobashi, Keiji Kita, Kohsaku Sakaguchi
Publikováno v:
Hepatology (Baltimore, Md.). 43(1)
In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to c
Autor:
Ryoji Tanaka, Toshinari Shimoe, Keiji Kita, Kouichi Takaguchi, Hiroshi Ikeda, Yasushi Shiratori, Masaharu Ando, Junnosuke Shimamura, Minoru Tomita, Koji Manabe, Tomonori Senoh, Kohsaku Sakaguchi, Toshitsugu Kobatake, Yoshiaki Iwasaki, Yasuyuki Araki, Mitsuhiko Kawaguchi, Yasuhiro Makino, Haruhiko Kobashi
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 24(6)
Background: Although a variety of papers demonstrated inhibited hepatocarcinogenesis with interferon (IFN) therapy for chronic hepatitis C, a small number of hepatocellular carcinomas (HCCs) were still observed even in sustained virologic responders.